ACT-HBV® : Advancing the Clinical Treatment of Hepatitis B Virus

Home	CME Center	Clinical Trials	About ACT-HBV^®	Treatment Algorithms and Guidelines	Ask the Experts



	HIV & Liver Disease 2008 Conference Jackson Hole, Wyoming 9.25.08

	48th Annual ICAAC/46th Annual IDSA Meeting Washington, DC 10.25.08

	International Association for the Study of Liver (IASL) San Francisco, CA 10.31.08

	View All Events

Clinical Trial Information
Updates on current clinical trials related to hepatitis B Virus

Ask the Experts
Submit your questions to
our Expert Panel

Treatment Algorithms
and Guidelines
Review recommended treatment algorithms and guidelines for optimal treatment

Treatment Algorithm for HBV

AASLD

EASL

APASL

Dept. of Health & Human Services: Coinfection

European Consensus: Coinfection



	6.30.08	The case for combination antiviral therapy for chronic hepatitis B virus infection The Lancet Infectious Diseases

	6.30.08	Treatment of chronic hepatitis B: Recommendations from an Italian workshop Digestive and Liver Diseases

	6.27.08	Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users American Journal of Preventive Medicine

	6.27.08	Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus Scandinavian Journal of Gastroenterology

	6.27.08	Treatment of chronic hepatitis B infection: An update of Swedish recommendations Scandinavian Journal of Infectious Diseases

View All News



	CME-accredited Wall Poster This CME-accredited Wall Poster "Algorithm for the Screening, Diagnosis, and Treatment of Chronic Hepatitis B" provides information on current recommendations for the screening, vaccination, diagnosis, and management of HBV infection in an easy-to-read format. This educational program is accredited for a maximum 1.0 category 1 credits. Advancing the Clinical Treatment of Hepatitis B Virus Guest Expert Lecture Series View these case study examples of common clinical scenarios, presented by experts in Hepatitis B, to illustrate patient management principles. This educational program is accredited for a maximum of 1.5 category 1 credits.		CME-Accredited Web Symposium: Current Concepts in the Management of Chronic HBV in the Asia-Pacific Region will review the burden of HBV in the Asia Pacific region, diagnostic testing and the role of HBV DNA levels in the progression of the diseases. Recently reported clinical data and its implication on treatment is also discussed. This educational program is accredited for a maximum of 1.5 category 1 credits. CME-Accredited Educational Programs: Choose from educational CME-accredited programs on hepatitis B from our virtual library. Slides and supporting resources are also included.




		The ACT-HBV Initiative in the United States is supported by independent educational grants from Bristol-Myers Squibb Company and Gilead Sciences. The ACT-HBV Initiative in the Asia-Pacific Region is supported by independent educational grants from Bristol-Myers Squibb Company and Novartis Pharma AG.